688163 赛伦生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.7834.0613.5138.61023.029
总资产报酬率 ROA (%)5.6293.9403.3798.18121.393
投入资产回报率 ROIC (%)5.7444.0083.4468.38722.219

边际利润分析
销售毛利率 (%)78.42778.05775.70983.77083.682
营业利润率 (%)42.84126.67024.18442.85542.268
息税前利润/营业总收入 (%)41.91025.08422.67240.96441.803
净利润/营业总收入 (%)36.66322.72320.39236.84936.648

收益指标分析
经营活动净收益/利润总额(%)93.487101.80188.00678.66097.011
价值变动净收益/利润总额(%)10.26310.22322.75621.667-0.896
营业外收支净额/利润总额(%)-0.285-2.806-1.252-0.843-0.378

偿债能力分析
流动比率 (X)28.71646.70037.97937.10414.050
速动比率 (X)27.50344.49536.18835.07511.263
资产负债率 (%)3.1382.1903.7783.8458.256
带息债务/全部投入资本 (%)0.2850.2270.3330.2940.712
股东权益/带息债务 (%)34,893.27943,849.60829,465.78033,387.04513,386.062
股东权益/负债合计 (%)3,086.3734,465.3532,547.0122,500.4961,111.266
利息保障倍数 (X)-51.818-29.206-18.689-26.735-137.029

营运能力分析
应收账款周转天数 (天)78.51554.77528.69717.84111.392
存货周转天数 (天)293.115370.449386.922660.221522.744